Dodge & Cox – BMRN history
- Issuer:
- BioMarin Pharmaceutical, Inc.
- Quarters tracked:
- 26 (Q4 2019 → Q1 2026)
- Current shares:
- 14,561,759
- Current value:
- $822.59M
- Peak shares:
- 15,108,310 (Q2 2025)
- Overall change:
- +232%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q1 2026 | 14,561,759 | $822.59M | $56.49 | -10,625 | 0% |
| Q4 2025 | 14,572,384 | $866.04M | $59.43 | -114,417 | -1% |
| Q3 2025 | 14,686,801 | $795.44M | $54.16 | -421,509 | -3% |
| Q2 2025 | 15,108,310 | $830.50M | $54.97 | +153,070 | +1% |
| Q1 2025 | 14,955,240 | $1.06B | $70.69 | +209,005 | +1% |
| Q4 2024 | 14,746,235 | $969.27M | $65.73 | +847,917 | +6% |
| Q3 2024 | 13,898,318 | $976.91M | $70.29 | -32,175 | 0% |
| Q2 2024 | 13,930,493 | $1.15B | $82.33 | -62,450 | 0% |
| Q1 2024 | 13,992,943 | $1.22B | $87.34 | -1,120 | 0% |
| Q4 2023 | 13,994,063 | $1.35B | $96.42 | -159,440 | -1% |
| Q3 2023 | 14,153,503 | $1.25B | $88.48 | -136,800 | -1% |
| Q2 2023 | 14,290,303 | $1.24B | $86.68 | -39,010 | 0% |
| Q1 2023 | 14,329,313 | $1.39B | $97.24 | -54,350 | 0% |
| Q4 2022 | 14,383,663 | $1.49B | $103.49 | -390,300 | -3% |
| Q3 2022 | 14,773,963 | $1.25B | $84.77 | -233,100 | -2% |
| Q2 2022 | 15,007,063 | $1.24B | $82.87 | -27,936 | 0% |
| Q1 2022 | 15,034,999 | $1.16B | $77.10 | +209,950 | +1% |
| Q4 2021 | 14,825,049 | $1.31B | $88.35 | +6,467 | 0% |
| Q3 2021 | 14,818,582 | $1.15B | $77.29 | +716,485 | +5% |
| Q2 2021 | 14,102,097 | $1.18B | $83.44 | +2,247,789 | +19% |
| Q1 2021 | 11,854,308 | $895.12M | $75.51 | +2,057,384 | +21% |
| Q4 2020 | 9,796,924 | $859.09M | $87.69 | +2,076,701 | +27% |
| Q3 2020 | 7,720,223 | $587.36M | $76.08 | +4,104,483 | +114% |
| Q2 2020 | 3,615,740 | $445.96M | $123.34 | -326,768 | -8% |
| Q1 2020 | 3,942,508 | $333.14M | $84.50 | -447,007 | -10% |
| Q4 2019 | 4,389,515 | $371.13M | $84.55 | — | NEW |